Legacy App users can now access the Health Portal – just reset your password using email as username.

Should You Use Semaglutide With An A1C Of 5.5?

Should You Use Semaglutide With An A1C Of 5.5?

Viewing This Video Is A Member Exclusive Feature

But you don’t need membership to get Dr. O’Connor’s insight on this topic, it’s in the summary, key takeaways, and related drugs and conditions below.

Want to watch the full video? Join the Health Portal Today.

Join Now

Timeline

Timestamp
Topic
00:00
A 53-year-old man with an A1C of 5.5 asks about semaglutide, and Dr. O’Connor explains why the A1C itself does not indicate prediabetes while discussing weight loss and metformin as alternative considerations.

Video Summary

A 53-year-old man with an A1C of 5.5 asks whether semaglutide is appropriate. Dr. O’Connor explains that an A1C of 5.5 is not in the prediabetes range and does not by itself justify semaglutide for glucose control.

Semaglutide may still have value when weight loss is the primary goal, but Dr. O’Connor questions whether it is something a patient should expect to remain on indefinitely. He instead discusses metformin extended release as another option, along with maintaining a clean diet and healthy body weight.

The key distinction is why the medication is being considered. Semaglutide is used for weight loss and diabetes, while this member does not have diabetes based on the information provided.

Drug Callouts

Drug
Description
Semaglutide
Semaglutide is being considered despite the member having an A1C of 5.5. Dr. O’Connor explains that the medication may be useful for weight loss and diabetes but does not believe this A1C alone provides a reason to use it for glucose control.
Metformin
Dr. O’Connor discusses metformin extended release at 500 to 750 mg at night as another possible option while emphasizing diet and maintaining a healthy body weight.

Key Takeaways

  • An A1C of 5.5 is below the prediabetes threshold and does not by itself justify semaglutide for glucose control.
  • Semaglutide may still be considered for weight loss even when a patient does not have diabetes.
  • Dr. O’Connor questions whether semaglutide should be viewed as a medication a patient remains on indefinitely.
  • Metformin extended release is discussed as another option alongside a clean diet and maintaining a healthy body weight.